Συντονιστές
          
      Presentations
T-CELL RECEPTOR AND IMMUNE-RESPONSE GENE STUDIES IN P. Batsaki TUMOR MICROENVI-RONMENT AND PERIPHERAL BLOOD IN HEAD AND NECK CANCER PATIENTS
      
      
  
        
  THE TCR Vβ REPERTOIRE COMPOSITION AS A PREDICTIVE BIOMARKER OF IMMUNOTHERAPY EFFICIENCY IN NON-SMALL CELL LUNG CANCER PATIENTS
      
      
  
        
  KMT2C IS A TUMOR SUPPRESSOR IN BLADDER CANCER AND ITS LOSS LEADS TO FAVORABLE RESPONSE TO IMMUNOTHERAPY
      
      
  
        
  REAL-WORLD DATA ON IMMUNOTHERAPY IN PATIENTS WITH SOFT TISSUE SARCOMA: A STUDY FROM THE HELLENIC GROUP OF SARCOMA AND RARE CANCERS